Intravitreal Ozurdex implant for Macular Oedema following CRVO. Figure 1 showed CMO (pretreament stage)
Intravitreal Ozurdex implant for Macular Oedema following CRVO. Figure 1 showed CMO (pretreament stage)
A 59 year old lady with history of left CRVO in August 2012. Later on she had developed cystoid macular oedema (CMO) which was non resolving (Figure 1). We have decided to give her an intravitreal injection of Ozurdex (Dexamethasone Intravitreal Implant, 0.7mg). She had the injection in 16/04/2013. Six weeks later, SD-OCT (Spectralis, Heidelberg) scan of the left macula showed a complete resolution of the CMO. Vision has improved from 0.7 LogMar to 0.4 LogMar.
Al-Aqaba, Mouhamed Ali Abdul Kareem, Ph.D., Rotherham Hospital NHS Foundation Trust, Rotherham, United Kingdom; Thakur, Shakti, M.D., Rotherham Hospital NHS Foundation Trust, Rotherham, United Kingdom
